Dose effect of tumor necrosis factor-α on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds

Biomaterials

Volumn 31, Issue 7, 2010, Pages 1666-1675

  Mountziaris, Paschalia M ^a   Tzouanas, Stephanie N ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

Author keywords

Biomineralisation; Bone tissue engineering; Cytokine; Inflammation; Mesenchymal stem cells; Osteogenesis

Indexed keywords

BIOMINERALISATION; BONE TISSUE ENGINEERING; CYTOKINES; MESENCHYMAL STEM CELL; OSTEOGENESIS;

BIODEGRADABLE POLYMERS; BONE; DRUG PRODUCTS; FLOWCHARTING; GLYCOPROTEINS; MACROPHAGES; PATHOLOGY; SCAFFOLDS; STEM CELLS; STRATEGIC PLANNING; TISSUE ENGINEERING; TUMORS;

CELL CULTURE;

DEXAMETHASONE; POLYCAPROLACTONE; POLYMER; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TISSUE SCAFFOLD; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BIODEGRADABILITY; BONE DEVELOPMENT; BONE MINERALIZATION; BONE TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE TECHNIQUE; FIBER; IN VITRO STUDY; INFLAMMATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; CALCIUM; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; POLYESTERS; POLYMERS; RATS; TISSUE SCAFFOLDS; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 73249114253     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.058     Document Type: Article

References (37)

1. Ingber D.E., and Levin M. What lies at the interface of regenerative medicine and developmental biology. Development 134 (2007) 2541-2547
2. Rundle C.H., Wang H., Yu H., Chadwick R.B., Davis E.I., Wegedal J.E., et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone 38 (2006) 521-529
3. Hecht J., Kuhl H., Haas S.A., Bauer S., Poustka A.J., Lienau J., et al. Gene identification and analysis of transcripts differentially regulated in fracture healing by EST sequencing in the domestic sheep. BMC Genomics 7 (2006) 172
4. Pham Q.P., Kasper F.K., Baggett L.S., Raphael R.M., Jansen J.A., and Mikos A.G. The influence of the in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials 29 18 (2008) 2729-2739
5. Lin C.-C., Metters A.T., and Anseth K.S. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNF[alpha]. Biomaterials 30 28 (2009) 4907-4914
6. Mountziaris P.M., and Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14 2 (2008) 179-186
7. Guo R., Yamashita M., Zhang Q., Zhou Q., Chen D., Reynolds D.G., et al. Ubiquitin ligase smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 283 34 (2008) 23084-23092
8. Ding J., Ghali O., Lencel P., Broux O., Chauveau C., Devedjian J.C., et al. TNF-[alpha] and IL-1[beta] inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 84 15-16 (2009) 499-504
9. Lacey D.C., Simmons P.J., Graves S.E., and Hamilton J.A. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthr Cartil 17 6 (2009) 735-742
10. Hess K., Ushmorov A., Fiedler J., Brenner R.E., and Wirth T. TNF[alpha] promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-[kappa]B signaling pathway. Bone 45 2 (2009) 367-376
11. Kon T., Cho T.-J., Aizawa T., Yamazaki M., Nooh N., Graves D.T., et al. Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegrin ligand) and related pro-inflammatory cytokines during fracture healing. J Bone Miner Res 16 6 (2001) 1004-1014
12. Gerstenfeld L.C., Cullinane D.M., Barnes G.L., Graves D.T., and Einhorn T.A. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88 (2003) 873-884
13. Gerstenfeld L.C., Cho T.-J., Kon T., Aizawa T., Tsay A., Fitch J., et al. Impaired fracture healing in the absence of TNF-α signaling: the role of TNF-α in endochondral cartilage resorption. J Bone Miner Res 18 9 (2003) 1584-1592
14. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Cruceta J., Graves B.D., et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 169 3 (2001) 285-294
15. Jaiswal N., Haynesworth S.E., Caplan A.I., and Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64 (1997) 295-312
16. Peter S.J., Liang C.R., Kim D.J., Widmer M.S., and Mikos A.G. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and l-ascorbic acid. J Cell Biochem 71 (1998) 55-62
17. Datta N., Holtorf H.L., Sikavitsas V.I., Jansen J.A., and Mikos A.G. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 26 9 (2005) 971-977
18. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353 16 (2005) 1711-1723
19. Balga R., Wetterwald A., Portenier J., Dolder S., Mueller C., and Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 39 2 (2006) 325-335
20. Datta N., Pham Q.P., Sharma U., Sikavitsas V.I., Jansen J.A., and Mikos A.G. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A 103 8 (2006 Feb 21) 2488-2493
21. Pham Q.P., Sharma U., and Mikos A.G. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng 12 5 (2006) 1197-1211
22. Pham Q.P., Sharma U., and Mikos A.G. Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules 7 10 (2006) 2796-2805
23. Gomes M.E., Bossano C.M., Johnston C.M., Reis R.L., and Mikos A.G. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 12 1 (2006) 177-188
24. Gomes M.E., Holtorf H.L., Reis R.L., and Mikos A.G. Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng 12 4 (2006) 801-809
25. Martins A.M., Pham Q.P., Malafaya P.B., Sousa R.A., Gomes M.E., Raphael R.M., et al. The role of lipase and a-amylase in the degradation of starch/poly(ε-caprolactone) fiber meshes and the osteogenic differentiation of cultured marrow stromal cells. Tissue Eng Part A 15 2 (2009) 295-305
26. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 5309 (1997) 71-74
27. Lewis M., Tartaglia L.A., Lee A., Bennett G.L., Rice G.C., Wong G.H., et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A 88 7 (1991) 2830-2834
28. Merchant F.A., and Periasamy A. Correction using calibration images. In: Wu Q., Merchant F.A., and Castleman K.R. (Eds). Microscope image processing (2008), Elsevier, Burlington 258
29. Pape H.-C., Schmidt R.E., Rice J., van Griensven M., das Gupta R., Krettek C., et al. Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. Crit Care Med 28 10 (2000) 3441-3448
30. Iqbal J., Sun L., Kumar T.R., Blair H.C., and Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A 103 40 (2006) 14925-14930
31. Young S., Patel Z.S., Kretlow J.D., Murphy M.B., Mountziaris P.M., Baggett L.S., et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15 (2009) 2347-2362
32. Gilbert L., He X., Farmer P., Boden S., Kozlowski M., Rubin J., et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141 11 (2000) 3956-3964
33. Taichman R.S., and Hauschka P.V. Effects of interleukin-1β and tumor necrosis factor-α on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation 16 6 (1992) 587-601
34. Gilbert L.C., Rubin J., and Nanes M.S. The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab 288 5 (2005) E1011-E1018
35. Castano-Izquierdo H., Alvarez-Barreto J., van den Dolder J., Jansen J.A., Mikos A.G., and Sikavitsas V.I. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A 82 1 (2007) 129-138
36. Paula-Silva F.W.G., Ghosh A., Silva L.A.B., and Kapila Y.L. TNF-{alpha} promotes an odontoblastic phenotype in dental pulp cells. J Dent Res 88 4 (2009) 339-344
37. Tintut Y., Patel J., Parhami F., and Demer L.L. Tumor necrosis factor-{alpha} promotes in vitro calcification of vascular cells via the cAMP Pathway. Circulation 102 21 (2000) 2636-2642